Arkolith/Insider Trading/QNRX/Form 4

Langer Dennis

DirectorQuoin Pharmaceuticals, Ltd. (QNRX) · full profile →Form 4 · filed Jun 10, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$217
Net Open-Market Flow
-$217
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 7, 2024Sell(S)297$0.73$21753

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-070017) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML